Skip to Content

GSI 7916 (Epclusa sofosbuvir 400 mg / velpatasvir 100 mg)

Generic Name: sofosbuvir/velpatasvir

Pill with imprint GSI 7916 is Pink, Four-sided and has been identified as Epclusa sofosbuvir 400 mg / velpatasvir 100 mg. It is supplied by Gilead Sciences, Inc..

Epclusa is used in the treatment of hepatitis c and belongs to the drug class antiviral combinations. Epclusa sofosbuvir 400 mg / velpatasvir 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI 7916

Epclusa sofosbuvir 400 mg / velpatasvir 100 mg GSI 7916
Epclusa sofosbuvir 400 mg / velpatasvir 100 mg GSI 7916
Epclusa sofosbuvir 400 mg / velpatasvir 100 mg GSI 7916

Epclusa

Generic Name:
sofosbuvir/velpatasvir
Imprint:
GSI 7916
Strength:
sofosbuvir 400 mg / velpatasvir 100 mg
Color:
Pink
Shape:
Four-sided
Availability:
Prescription only
Drug Class:
Antiviral combinations
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Gilead Sciences, Inc.
National Drug Code (NDC):
61958-2201

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide